Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (7073)	4/15/1998 5:30:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, I could understand vivus at 8 if the FDA recalled the product or if MUSE was ineffective. This company was founded by many doctors. If they did not believe in the potential of MUSE as a local non needle ED solution, they would not be moving forward on plans for expansion. No doubt Viagra will be a blockbuster, but MUSE will still have its place in the ED market. I SERIOUSLY believe we will soon see a buy out of vivus if it lingers in single digits for more than a few weeks. I will personally attempt to speak to Wilson and then post this week.